Supplementary information from A20 and RBX1 Regulate Brentuximab Vedotin Sensitivity in Hodgkin Lymphoma Models
Year: 2023
Type: supplementary-materials
Abstract: Supplementary Information. Including Supplemental Experimental Procedures, and Supplementary Figure 1-6.
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4362139006
